Bölge seçiniz

Konuya göre filtrele

2026-03-02

From pioneer to practice: the evolution of ECMO in modern critical care

Over the past two decades, extracorporeal membrane oxygenation has undergone a remarkable transformation. Advances in mobility, system integration, and clinical experience have expanded where and how ECMO can be used — changing its role from a highly specialized stationary intervention into a widely applicable form of life-sustaining support in modern critical care.

Yoğun Bakım
30.09.2025

ECMO for severe ARDS: Navigating global guidelines

Venovenous extracorporeal membrane oxygenation (VV-ECMO) has become a vital therapeutic option in managing severe acute respiratory distress syndrome (ARDS) when conventional interventions fail. The American Thoracic Society (ATS) in 2024 and the European Society of Intensive Care Medicine (ESICM) in 2023 released updated guidelines addressing the role of VV-ECMO. This article provides an overview of both guidelines, outlining their common ground and key distinctions without evaluating or favoring one approach over another.

Yoğun Bakım
22.07.2024

Selecting the right equipment for aseptic processing

During sterile manufacturing, human operators pose the greatest risk for product contamination. To reduce microbiological and particulate contamination risks, aseptic techniques typically rely on either laminar flow equipment used within a cleanroom environment or barrier technology. Laminar flow equipment includes laminar flow hoods and biosafety cabinets (Class I, Class II, and Class III). Barrier technology includes restricted access barrier systems (RABS) and isolators.

Farmasötik Üretim
8.12.2023

Effective containment solutions for potent APIs

Discover how our DPTE® rapid transfer port, tested in collaboration with SafeBridge® Regulatory & Life Sciences Group, ensures personnel and environmental safety in pharmaceutical manufacturing facilities. Read the assessment of containment performance, validating the effectiveness of the DPTE® Alpha port against potentially hazardous active pharmaceutical ingredients.

Farmasötik Üretim